Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 13 studies | 46% ± 21% | |
glutamatergic neuron | 6 studies | 43% ± 27% | |
GABAergic neuron | 5 studies | 48% ± 19% | |
retinal pigment epithelial cell | 3 studies | 37% ± 17% | |
interneuron | 3 studies | 58% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 34% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 3303.16 | 2584 / 2642 | 76% | 4.12 | 539 / 705 |
intestine | 49% | 266.92 | 470 / 966 | 0% | 0 | 0 / 527 |
blood vessel | 37% | 179.20 | 495 / 1335 | 0% | 0 | 0 / 0 |
muscle | 20% | 102.21 | 164 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 3% | 13.16 | 7 / 258 | 17% | 0.40 | 38 / 230 |
stomach | 17% | 102.26 | 62 / 359 | 1% | 0.02 | 3 / 286 |
liver | 9% | 35.24 | 20 / 226 | 1% | 0.08 | 4 / 406 |
bladder | 10% | 50.14 | 2 / 21 | 0% | 0.00 | 1 / 504 |
prostate | 2% | 12.32 | 6 / 245 | 4% | 0.25 | 19 / 502 |
esophagus | 4% | 20.23 | 64 / 1445 | 1% | 0.01 | 1 / 183 |
uterus | 1% | 1.65 | 1 / 170 | 4% | 0.17 | 17 / 459 |
breast | 0% | 0 | 0 / 459 | 4% | 0.18 | 41 / 1118 |
pancreas | 0% | 0 | 0 / 328 | 3% | 0.10 | 5 / 178 |
adipose | 2% | 7.29 | 24 / 1204 | 0% | 0 | 0 / 0 |
skin | 0% | 0.84 | 5 / 1809 | 1% | 0.03 | 5 / 472 |
ovary | 1% | 1.57 | 1 / 180 | 1% | 0.07 | 3 / 430 |
lung | 0% | 0 | 0 / 578 | 1% | 0.05 | 12 / 1155 |
heart | 1% | 3.60 | 8 / 861 | 0% | 0 | 0 / 0 |
kidney | 0% | 0 | 0 / 89 | 1% | 0.05 | 8 / 901 |
thymus | 0% | 0.64 | 1 / 653 | 0% | 0.01 | 1 / 605 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050806 | Biological process | positive regulation of synaptic transmission |
GO_0007399 | Biological process | nervous system development |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0099645 | Biological process | neurotransmitter receptor localization to postsynaptic specialization membrane |
GO_0007411 | Biological process | axon guidance |
GO_0031175 | Biological process | neuron projection development |
GO_0043083 | Cellular component | synaptic cleft |
GO_0005615 | Cellular component | extracellular space |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0030425 | Cellular component | dendrite |
GO_0005576 | Cellular component | extracellular region |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043194 | Cellular component | axon initial segment |
GO_0005737 | Cellular component | cytoplasm |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LGI1 |
Protein name | Leucine rich glioma inactivated 1 (Leucine-rich glioma inactivated 1 isoform 3) Leucine-rich glioma-inactivated protein 1 (Epitempin-1) Leucine-rich glioma-inactivated protein 1 Leucine rich glioma inactivated 1 |
Synonyms | hCG_2024350 EPT UNQ775/PRO1569 |
Description | FUNCTION: Regulates voltage-gated potassium channels assembled from KCNA1, KCNA4 and KCNAB1. It slows down channel inactivation by precluding channel closure mediated by the KCNAB1 subunit. Ligand for ADAM22 that positively regulates synaptic transmission mediated by AMPA-type glutamate receptors (By similarity). Plays a role in suppressing the production of MMP1/3 through the phosphatidylinositol 3-kinase/ERK pathway. May play a role in the control of neuroblastoma cell survival. . |
Accessions | ENST00000478763.2 ENST00000636946.1 O95970 A0A0D9SFH6 ENST00000638049.1 A0A0D9SFE3 ENST00000627420.2 A0A0S2Z4X3 ENST00000627699.1 A0A1B0GVP2 ENST00000371413.4 [O95970-2] A0A1B0GV33 A0A0D9SFS5 ENST00000637925.1 ENST00000636155.1 ENST00000629035.2 ENST00000371418.9 [O95970-1] ENST00000630487.2 ENST00000635953.1 ENST00000630184.2 ENST00000636754.1 ENST00000636232.1 A0A1B0GUD3 A0A0D9SFU4 ENST00000637611.1 ENST00000630047.2 [O95970-3] ENST00000637037.1 ENST00000637689.1 A0A0S2Z4S7 A0A0S2Z5G1 A0A1B0GTM5 A0A1B0GVF6 A0A1B0GWB4 |